CAT-5001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCAT-5001
Drug Alias NameSS1PSS(dsFv)-PE38SS1(dsFv)-PE38CAT-5001
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)
Mechanisms of ActionApoptosis stimulants
TargetsMesothelin
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsMesothelioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCambridge Antibody TechnologyAstrazeneca Pharmaceutical Co LtdInsys Therapeutics Inc +[4] 
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPancreatic NeoplasmsMesothelioma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A